Sarissa Capital Management LP Puma Biotechnology, Inc. Transaction History

Sarissa Capital Management LP

  • $402 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$6.5 - $10.73 $9.21 Million - $15.2 Million
-1,417,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$20.77 - $42.37 $1.54 Million - $3.14 Million
74,000 Added 5.51%
1,417,000 $55 Million
Q4 2018

Feb 14, 2019
BUY
$20.07 - $46.7 $27 Million - $62.7 Million
1,343,000 New
1,343,000 $27.3 Million

Others Institutions Holding PBYI

# of Institutions
101
Shares Held
29M
Call Options Held
50.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $139M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email